Cipla enters into JV agreement with Kemwell Biopharma

Cipla has entered into a joint venture agreement with Kemwell Biopharma on 25 August 2021 for incorporation of a joint venture company for undertaking the business of developing, applying for and obtaining licenses for and manufacturing, commercialising, importing and exporting biologic products and licensing or outsourcing of any or all such activities.

Powered by Capital Market - Live News